| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.2 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.2 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.064 | 0.2 |
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.2 |
| mRNA | CGP-082996 | GDSC1000 | pan-cancer | AAC | -0.072 | 0.2 |
| mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |